1-6 of 6 results for subject:Streptococcus
Librarians' tools
- Search time
- 0.208 seconds
- Solr query time
- 0.004 seconds
- Search query
- subject:Streptococcus
- We searched for
- subject_t:Streptococcus OR subject_t:"Strep A" OR subject_t:"Streptococcal infections" OR subject_ses:368447
Type
House
Session
Month
Department
Member
More
Primary member
Answering member
Legislative stage
Legislation
Subject
Publisher
That this House notes that this is Strep B Awareness Month; further notes that group B streptococcus is the most common cause of serious infection in newborn babies in the UK and is a leading cause of neonatal sepsis and meningitis; highlights that on average two babies each day in the UK develop a group B strep infection and that each week one baby dies from a group B strep infection and another is left with a life-changing disability; further highlights that the UK does not routinely test pregnant women for group B strep, unlike the US, Canada, Germany, France, Spain and many other developed countries where all mothers-to-be are tested; and encourages the Department of Health and Social Care to consider introducing a standard test throughout the UK for pregnant women between 35 and 37 weeks' gestation.
That this House notes that this is Strep B Awareness Month; further notes that group B streptococcus is the most common cause of serious infection in newborn babies in the UK and is a leading cause of neonatal sepsis and meningitis; highlights that on average two babies each day in...
To ask the Secretary of State for Health and Social Care, what assessment he has made of the recent outbreak of group A streptococcal bacterial strain.
To ask the Secretary of State for Health and Social Care, what assessment he has made of the recent outbreak of group A streptococcal bacterial strain.
12 people have died while a further 20 cases have been reported, many among elderly people with existing health conditions. The infection risk of contracting group A streptococcal bacterial strain to the public is very low. Treatment with antibiotics is very effective, if started early enough. The local National Health Service continues to work closely with Public Health England and other partners to manage this local incident, and extra infection control measures have been put in place to prevent the infection spreading in the area.
To ask the Secretary of State for Health and Social Care, whether the Government will recognise July as International Group B Strep Awareness Month; and what progress has been made on improving (a) prevention and (b) awareness of group B streptococcus .
To ask the Secretary of State for Health and Social Care, whether the Government will recognise July as International Group B Strep Awareness Month; and what progress has been made on improving (a) prevention and (b) awareness of group B streptococcus .
The Department continues to support awareness of Group B streptococcus, alongside the wider international community.
Group B streptococcus is the leading cause of bacterial infection in newborn babies. The Government has recognised there are gaps in the evidence relating to this issue and the National Institute for Health Research has commissioned a trial to compare the clinical and cost effectiveness of universal screening compared with usual risk-based care, which will help to understand more about the potential benefits and harms of this approach.
This is a large-scale and ambitious trial, the results of which will be of interest to the United Kingdom National Screening Committee and will form one piece of the developing evidence picture to inform its future recommendations for screening for Group B streptococcus.
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 19 March 2019 to Question 230615, and with reference to evidence demonstrating a reduction in rates of Group B Streptococcus infection in Northern Ireland since mandatory reporting of confirmed cases in babies was introduced...
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 19 March 2019 to Question 230615, and with reference to evidence demonstrating a reduction in rates of Group B Streptococcus infection in Northern Ireland since mandatory reporting of confirmed cases in babies was introduced...
Statutory notification of infectious diseases provides a means to alert public health officials to the occurrence of suspected or confirmed case of a given disease to direct public health action to prevent infection in others. These regulations, standards and guidance can be viewed at the following links:
http://www.legislation.gov.uk/uksi/2010/659/contents/made
https://www.gov.uk/guidance/notifiable-diseases-and-causative-organisms-how-to-report
The majority of infant Group B Streptococcus cases occur sporadically rather than through spread between individuals. As such, there are no specific public health actions recommended at present following the identification of a single case. If new evidence emerges to suggest actions should be initiated, the addition of Group B Streptococcus to the schedule of notifiable diseases will be reviewed.
To ask the Secretary of State for Health and Social Care, if he will make invasive Group B Streptococcus infection a notifiable disease.
To ask the Secretary of State for Health and Social Care, if he will make invasive Group B Streptococcus infection a notifiable disease.
There are no plans to make Group B streptococcus infection a notifiable disease in England.
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure NHS Resolution's claims management system has an injury code specific to invasive Group B Streptococcus (GBS) infection to improve the quality of data collection on GBS clinical negligence cases.
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure NHS Resolution's claims management system has an injury code specific to invasive Group B Streptococcus (GBS) infection to improve the quality of data collection on GBS clinical negligence cases.
NHS Resolution handles clinical negligence claims on behalf of National Health Service organisations and independent sector providers of NHS care in England. All claims received are categorised against pre-defined ‘cause’ codes on its claims management system. The cause code refers to the main cause(s) of the incident in relation to the claim.
NHS Resolution has advised that it is in the process of considering a new cause code for ‘Neonatal’ with a possible sub-code for Group B streptococcus. A decision on this is expected by summer 2019.
NHS Resolution uses the codes to support the production of claims scorecards for NHS trusts which enables trusts to ascertain potential risks within their organisation and assess where local interventions are needed.